428 related articles for article (PubMed ID: 28369744)
1. The role of Hippo/yes-associated protein signalling in vascular remodelling associated with cardiovascular disease.
He J; Bao Q; Yan M; Liang J; Zhu Y; Wang C; Ai D
Br J Pharmacol; 2018 Apr; 175(8):1354-1361. PubMed ID: 28369744
[TBL] [Abstract][Full Text] [Related]
2. YAP and TAZ: a nexus for Hippo signaling and beyond.
Hansen CG; Moroishi T; Guan KL
Trends Cell Biol; 2015 Sep; 25(9):499-513. PubMed ID: 26045258
[TBL] [Abstract][Full Text] [Related]
3. Hippo signaling in the kidney: the good and the bad.
Wong JS; Meliambro K; Ray J; Campbell KN
Am J Physiol Renal Physiol; 2016 Aug; 311(2):F241-8. PubMed ID: 27194720
[TBL] [Abstract][Full Text] [Related]
4. Stressing out the Hippo/YAP signaling pathway: toward a new role in Schwann cells.
Melfi S; Colciago A; Giannotti G; Bonalume V; Caffino L; Fumagalli F; Magnaghi V
Cell Death Dis; 2015 Oct; 6(10):e1915. PubMed ID: 26469964
[No Abstract] [Full Text] [Related]
5. Large tumor suppressor homologs 1 and 2 regulate mouse liver progenitor cell proliferation and maturation through antagonism of the coactivators YAP and TAZ.
Yi J; Lu L; Yanger K; Wang W; Sohn BH; Stanger BZ; Zhang M; Martin JF; Ajani JA; Chen J; Lee JS; Song S; Johnson RL
Hepatology; 2016 Nov; 64(5):1757-1772. PubMed ID: 27531557
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin-converting enzyme 2 activation suppresses pulmonary vascular remodeling by inducing apoptosis through the Hippo signaling pathway in rats with pulmonary arterial hypertension.
Yan D; Li G; Zhang Y; Liu Y
Clin Exp Hypertens; 2019; 41(6):589-598. PubMed ID: 30806090
[No Abstract] [Full Text] [Related]
7. The Hippo pathway in the heart: pivotal roles in development, disease, and regeneration.
Wang J; Liu S; Heallen T; Martin JF
Nat Rev Cardiol; 2018 Nov; 15(11):672-684. PubMed ID: 30111784
[TBL] [Abstract][Full Text] [Related]
8. Hippo pathway regulation of gastrointestinal tissues.
Yu FX; Meng Z; Plouffe SW; Guan KL
Annu Rev Physiol; 2015; 77():201-27. PubMed ID: 25293527
[TBL] [Abstract][Full Text] [Related]
9. The Hippo-YAP pathway in various cardiovascular diseases: Focusing on the inflammatory response.
Zheng A; Chen Q; Zhang L
Front Immunol; 2022; 13():971416. PubMed ID: 36059522
[TBL] [Abstract][Full Text] [Related]
10. Roles of YAP in mediating endothelial cell junctional stability and vascular remodeling.
Choi HJ; Kwon YG
BMB Rep; 2015 Aug; 48(8):429-30. PubMed ID: 26169195
[TBL] [Abstract][Full Text] [Related]
11. The hippo pathway effector Yes-associated protein promotes epithelial proliferation and remodeling in chronic rhinosinusitis with nasal polyps.
Deng H; Sun Y; Wang W; Li M; Yuan T; Kong W; Huang X; Long Z; Chen Z; Wang D; Yang Q
Allergy; 2019 Apr; 74(4):731-742. PubMed ID: 30362580
[TBL] [Abstract][Full Text] [Related]
12. Oxidized low-density lipoprotein promotes vascular endothelial cell dysfunction by stimulating miR-496 expression and inhibiting the Hippo pathway effector YAP.
Hu J; Liu T; Zhang Z; Xu Y; Zhu F
Cell Biol Int; 2019 May; 43(5):528-538. PubMed ID: 30811087
[TBL] [Abstract][Full Text] [Related]
13. Palmitic acid dysregulates the Hippo-YAP pathway and inhibits angiogenesis by inducing mitochondrial damage and activating the cytosolic DNA sensor cGAS-STING-IRF3 signaling mechanism.
Yuan L; Mao Y; Luo W; Wu W; Xu H; Wang XL; Shen YH
J Biol Chem; 2017 Sep; 292(36):15002-15015. PubMed ID: 28698384
[TBL] [Abstract][Full Text] [Related]
14. Hippo-yap signaling in ocular development and disease.
Lee M; Goraya N; Kim S; Cho SH
Dev Dyn; 2018 Jun; 247(6):794-806. PubMed ID: 29532607
[TBL] [Abstract][Full Text] [Related]
15. The Hippo pathway effector YAP controls mouse hepatic stellate cell activation.
Mannaerts I; Leite SB; Verhulst S; Claerhout S; Eysackers N; Thoen LF; Hoorens A; Reynaert H; Halder G; van Grunsven LA
J Hepatol; 2015 Sep; 63(3):679-88. PubMed ID: 25908270
[TBL] [Abstract][Full Text] [Related]
16. Beyond the Cardiomyocyte: Consideration of HIPPO Pathway Cell-Type Specificity.
Del Re DP
Circ Res; 2018 Jun; 123(1):30-32. PubMed ID: 29929975
[TBL] [Abstract][Full Text] [Related]
17. [The world according to YAP: a continuous cross-talk between Wnt and Hippo pathways].
Gilgenkrantz H
Med Sci (Paris); 2013 Oct; 29(10):868-74. PubMed ID: 24148125
[TBL] [Abstract][Full Text] [Related]
18. TGF-β/Smads signaling pathway, Hippo-YAP/TAZ signaling pathway, and VEGF: Their mechanisms and roles in vascular remodeling related diseases.
Liu H; Sun M; Wu N; Liu B; Liu Q; Fan X
Immun Inflamm Dis; 2023 Nov; 11(11):e1060. PubMed ID: 38018603
[TBL] [Abstract][Full Text] [Related]
19. YAP/TAZ for cancer therapy: opportunities and challenges (review).
Guo L; Teng L
Int J Oncol; 2015 Apr; 46(4):1444-52. PubMed ID: 25652178
[TBL] [Abstract][Full Text] [Related]
20. JCAD, a Gene at the 10p11 Coronary Artery Disease Locus, Regulates Hippo Signaling in Endothelial Cells.
Jones PD; Kaiser MA; Ghaderi Najafabadi M; Koplev S; Zhao Y; Douglas G; Kyriakou T; Andrews S; Rajmohan R; Watkins H; Channon KM; Ye S; Yang X; Björkegren JLM; Samani NJ; Webb TR
Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1711-1722. PubMed ID: 29794114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
